HIV treatment has come a long way since the early days of the epidemic. Patients can now take various combinations of dozens of medications keep the virus under control and halt their disease from decimating their immune systems and leading to more serious, often fatal outcomes. But harnessing HIV requires daily vigilance. Missing doses of the […]

Psychiatry drug development is historically a challenging space to navigate, but Seth Lederman, CEO of Tonix Pharmaceuticals, is unwavering in his mission to develop the next therapy for post-traumatic stress disorder (PTSD). Dr. Lederman shares key learning for Tonix’s recent clinical trials and how they are using their expertise to provide relief to unmet patient […]

As Sutro Biopharma Inc. launched an early-stage clinical trial of an experimental cancer-fighting drug, it started patients at a less-than-effective dose, quickly escalating the amount of the drug it pumps into patients and expanding to a broad range of cancers. The process may sound like a no-brainer, but smaller biotech companies for years were forced to take a […]